The 22q11.2 Deletion Syndrome in Congenital Heart Defects: Prevalence of Microdeletion Syndrome in Cameroon

Global Heart ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. 115 ◽  
Author(s):  
Ambroise Wonkam ◽  
Ricardo Toko ◽  
David Chelo ◽  
Cedrik Tekendo-Ngongang ◽  
Samuel Kingue ◽  
...  
2016 ◽  
Vol 135 (3) ◽  
pp. 273-285 ◽  
Author(s):  
Elisabeth E. Mlynarski ◽  
◽  
Michael Xie ◽  
Deanne Taylor ◽  
Molly B. Sheridan ◽  
...  

2016 ◽  
Vol 175 ◽  
pp. 116-122.e4 ◽  
Author(s):  
Niels B. Matthiesen ◽  
Peter Agergaard ◽  
Tine B. Henriksen ◽  
Cathrine C. Bach ◽  
J. William Gaynor ◽  
...  

Author(s):  
Rafael Fabiano Machado Rosa ◽  
Patrícia Trevisan ◽  
Dayane Bohn Koshiyama ◽  
Carlo Benatti Pilla ◽  
Paulo Ricardo Gazzola Zen ◽  
...  

2011 ◽  
Vol 57 (1) ◽  
pp. 62-65 ◽  
Author(s):  
Rafael Fabiano Machado Rosa ◽  
Patrícia Trevisan ◽  
Dayane Bohn Koshiyama ◽  
Carlo Benatti Pilla ◽  
Paulo Ricardo Gazzola Zen ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Sathiya Maran ◽  
Siti Aisyah Faten ◽  
Swee-Hua Erin Lim ◽  
Kok-Song Lai ◽  
Wan Pauzi Wan Ibrahim ◽  
...  

Background. The 22q11.2 deletion syndrome (22q11.2DS) is the most common form of deletion disorder in humans. Low copy repeats flanking the 22q11.2 region confers a substrate for nonallelic homologous recombination (NAHR) events leading to rearrangements which have been reported to be associated with highly variable and expansive phenotypes. The 22q11.2DS is reported as the most common genetic cause of congenital heart defects (CHDs). Methods. A total of 42 patients with congenital heart defects, as confirmed by echocardiography, were recruited. Genetic molecular analysis using a fluorescence in situ hybridization (FISH) technique was conducted as part of routine 22q11.2DS screening, followed by multiplex ligation-dependent probe amplification (MLPA), which serves as a confirmatory test. Results. Two of the 42 CHD cases (4.76%) indicated the presence of 22q11.2DS, and interestingly, both cases have conotruncal heart defects. In terms of concordance of techniques used, MLPA is superior since it can detect deletions within the 22q11.2 locus and outside of the typically deleted region (TDR) as well as duplications. Conclusion. The incidence of 22q11.2DS among patients with CHD in the east coast of Malaysia is 0.047. MLPA is a scalable and affordable alternative molecular diagnostic method in the screening of 22q11.2DS and can be routinely applied for the diagnosis of deletion syndromes.


2020 ◽  
Vol 09 (04) ◽  
pp. 227-234
Author(s):  
Bruna Lixinski Diniz ◽  
Andressa Schneiders Santos ◽  
Andressa Barreto Glaeser ◽  
Bruna Baierle Guaraná ◽  
Cláudia Fernandes Lorea ◽  
...  

Abstract22q11.2 deletion syndrome (22q11.2DS) is considered one of the most frequently observed chromosomal abnormalities in association with congenital heart disease (CHD), which can also include some combination of other features. Thus, the aim of this work was to verify the profile of dysmorphic features and heart defects found in patients referred to a reference center in Southern Brazil with clinical findings suggestive of 22q11.2DS. In the overall sample group, only patients with dysmorphic facial features (skull, eyes, ear, and nose) associated with CHD (obstructive pulmonary valve ring, truncus arteriosus, and bicuspid aortic valve associated with atrial septal defect and/or right aortic arch) had a 22q11.2 deletion. These findings proved to be reliable clinical criteria for referral to perform fluorescent in situ hybridization investigation for 22q11.2 deletion.


Author(s):  
I.V. Novikova, O.M. Khurs, T.V. Demidovich et all

16 second trimester fetuses with 22q11.2 deletion syndrome have been examined at anatomic-pathological investigation. Main cardiovascular diseases were ascending aorta hypoplasia with aortic valve stenosis (n = 6; 37.5%), truncus arteriosus (n = 5; 31.25%), tetralogy of Fallot (n = 3; 18.75%) and double-outlet right ventricle (n = 1; 6.25%). Ventricular septal defect was present in 16 cases. Associated aortic arch anomalies included interrupted aortic arch (n = 9; 56.25%), right aortic arch (n = 6; 37.5%), retroesophageal ring (n = 1; 6.25%) and aberrant right subclavian arteria (n = 5; 31.25%). 5 fetuses had left ventricular outflow tract obstructive lesions with interrupted aortic arch of type B combined with aberrant right subclavian arteria.


Sign in / Sign up

Export Citation Format

Share Document